11 min read
Monthly FDA Guidance and Regulatory News Review - September 2026
This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...
Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.
Learn More →
Meet our experienced #Veristat Head of Global Medical Affairs, Atalah Haun, MD, at ESMO - European Society for Medical Oncology in Paris September 9 –13. Don´t miss the opportunity to discuss your clinical program with Veristat.
With more than 27 years of experience in clinical trial planning and execution, Veristat is equipped to support any development program.
Whether you have a compound and need to get started on your IND, or want to recruit patients quickly to get your early phase trials running, or just need medical writing or biostatistical support for your programs - Veristat can help.
We provide impactful drug development and regulatory solutions on both a full-service or functional service basis.
Schedule a meeting with Atalah Haun, MD by filling out the form on the right. Find out how we can help you advance your next clinical trial or regulatory submission to successful outcomes.
Website: https://www.esmo.org/meetings/esmo-congress-2022/registrationhttps://informaconnect.com/bioeurope/
9th-13th September 2022 , Paris

11 min read
Oct 21, 2026 Veristat Blog
This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...
8 min read
Sep 21, 2026 Veristat Blog
This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...